Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 3/20 | 0.46 |
| ▸ | SRC | P12931 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3263155 | 0.87 | LMNA (0.72) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL23137230 | 0.81 | LMNA (0.66) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL24700466 | 0.81 | LMNA (0.66) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL9479429 | 0.81 | LMNA (0.74) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL490778 | 0.79 | NPC1 (0.43) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL6492979 | 0.79 | MEN1 (0.59) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL23137231 | 0.79 | LMNA (0.62) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL3906094 | 0.79 | MAPK1 (0.62) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL10985991 | 0.79 | NPC1 (0.78) | LMNAHPGDALDH1A1MAPTFFAR1 | |
| SCHEMBL6097608 | 0.78 | RAB9A (0.50) | LMNAHPGDALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113038734-B | Organic metal solderability preservative, preparation method and application of organic metal solderability preservative film | 广州三孚新材料科技股份有限公司 | 2022-02-15 | — | — | CN | claimed |
| CN-113038734-A | Organic metal solderability preservative, preparation method and application of organic metal solderability preservative film | 广州三孚新材料科技股份有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-113038734-B | Organic metal solderability preservative, preparation method and application of organic metal solderability preservative film | 广州三孚新材料科技股份有限公司 | 2022-02-15 | — | — | CN | disclosed |
| CN-113038734-A | Organic metal solderability preservative, preparation method and application of organic metal solderability preservative film | 广州三孚新材料科技股份有限公司 | 2021-06-25 | — | — | CN | disclosed |
| EP-3130465-B1 | HEAT-SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA NV (BE) | 2020-05-13 | — | — | EP | disclosed |
| EP-3130465-B1 | HEAT-SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA NV (BE) | 2020-05-13 | — | — | EP | disclosed |
| US-20180236759-A1 | HEAT-SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA NV (BE) | 2018-08-23 | — | — | US | disclosed |
| WO-2017025307-A1 | HEAT-SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA GRAPHICS NV (BE) | 2017-02-16 | — | — | WO | disclosed |
| WO-2017025307-A1 | HEAT-SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA GRAPHICS NV (BE) | 2017-02-16 | — | — | WO | disclosed |
| EP-3130465-A1 | HEAT-SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA GRAPHICS NV (BE) | 2017-02-15 | — | — | EP | disclosed |
| EP-3130465-A1 | HEAT-SENSITIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR | AGFA GRAPHICS NV (BE) | 2017-02-15 | — | — | EP | disclosed |
| US-8241740-B2 | Layer laminated to support; ionization radiation; curing using free radical catalyst; image display and polarization plates | FUJIFILM CORPORATION (JP) | 2012-08-14 | — | — | US | disclosed |
| US-20120168681-A1 | Surface Modified Metal Nano-Particle and Use Thereof | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2012-07-05 | — | — | US | disclosed |
| EP-2452683-A2 | Methods for treating atherosclerosis | Amgen Inc. (US) | 2012-05-16 | — | — | EP | disclosed |
| EP-2037928-B1 | METHODS FOR TREATING ATHEROSCLEROSIS | AMGEN INC (US) | 2012-01-11 | — | — | EP | disclosed |
| US-20110206652-A1 | METHODS FOR TREATING ATHEROSCLEROSIS | AMGEN INC. (US) | 2011-08-25 | — | — | US | disclosed |
| EP-2037928-A2 | METHODS FOR TREATING ATHEROSCLEROSIS | Amgen Inc. (US) | 2009-03-25 | — | — | EP | disclosed |
| US-20080096900-A1 | Methods for treating atherosclerosis | AMGEN INC. (US) | 2008-04-24 | — | — | US | disclosed |
| WO-2008002591-A2 | METHODS FOR TREATING ATHEROSCLEROSIS | AMGEN INC (US) | 2008-01-03 | — | — | WO | disclosed |
| EP-0403100-A2 | High sensitivity photopolymerizable compositions containing hydrogen donating mercaptans | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096900-A1 | Methods for treating atherosclerosis | LCAT, PCSK9, CETP | LMNA 535/4885HPGD 1390/4885ALDH1A1 2876/4885 |
| US-20110206652-A1 | METHODS FOR TREATING ATHEROSCLEROSIS | LCAT, PCSK9, CETP | LMNA 535/4885HPGD 1390/4885ALDH1A1 2876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.